Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.

Tobias Moser* (First author), Michael Seiberl (Co-author), Julia Feige (Co-author), Lara Bieler, Richard Friedrich Radlberger (Co-author), Ciara OSullivan, Georg Pilz (Co-author), Andrea Harrer (Co-author), Kerstin Schwenker (Co-author), Elisabeth Haschke-Becher (Co-author), Lukas Machegger (Co-author), Jochen Grimm (Co-author), Monika Redlberger-Fritz, Arabella Buchmann, Michael Khalil, Erich Kvas, Eugen Trinka (Co-author), Peter Wipfler (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)718895
JournalFRONTIERS IN IMMUNOLOGY
Volume12
DOIs
Publication statusPublished - Aug 2021

Keywords

  • SERUM NEUROFILAMENT LIGHT
  • RISK
  • BIOMARKER
  • TRIAL

Cite this